1-3 of 3
David Kuter, MD, DPhil
Close
Sort by
Journal Articles

An Ongoing Multinational Observational Study in Multiple Myeloma (PREAMBLE): Preliminary Report on Patient Survival

Gordon Cook, MD PhD, David Cella, PhD, Brian Durie, MD, Hartmut Goldschmidt, MD, David Kuter, MD DPhil, Philippe Moreau, Ravi Vij, MD MBBS, Catherine Davis, Abderrahim Oukessou, Teresa Zyczynski, PharmD, MPH, MBA, BSPharm, Sergey Popov, Antonio Palumbo, MD
Journal: Blood
Blood (2015) 126 (23): 2093.
https://doi.org/10.1182/blood.V126.23.2093.2093
Published: 2015
Journal Articles

Gestational Platelet Trends and Outcomes in Women with Myeloproliferative Disorders Characterized by Thrombocytosis

Annemarie E. Fogerty, MD, David Kuter, MD, DPhil, Jean M. Connors, MD
Journal: Blood
Blood (2008) 112 (11): 5251.
https://doi.org/10.1182/blood.V112.11.5251.5251
Published: 2008
Journal Articles

A Phase 2 Placebo Controlled Study Evaluating the Platelet Response and Safety of Weekly Dosing with a Novel Thrombopoietic Protein (AMG531) in Thrombocytopenic Adult Patients (pts) with Immune Thrombocytopenic Purpura (ITP).

David Kuter, MD, DPhil, James B. Bussel, MD, Louis M. Aledort, MD, James George, MD, Roger M. Lyons, MD, George T. Conklin, MD, Alan E. Lichtin, MD, Jorge Nieva, MD, Reggie Kelly, BA, Chien-Feng Chen, PhD, Janet L. Nichol, MS
Journal: Blood
Blood (2004) 104 (11): 511.
https://doi.org/10.1182/blood.V104.11.511.511
Published: 2004